Skip to content
10-Q

Quarterly Report

Impact BioMedical, INC. IBO

0001493152-25-021286

← back to feed
Filed
Nov 7, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 27, 2025 104.62M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$1.99M
Operating Cash Flow restated Q3 2025 · Sep 30, 2024 −$1.87M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $12K
Cash And Equivalents Q3 2025 · Dec 31, 2024 $2M
Stockholders Equity Q3 2025 · Sep 30, 2025 −$11.81M
Stockholders Equity Q3 2025 · Dec 31, 2024 $4.26M
Current Liabilities Q3 2025 · Sep 30, 2025 $23.79M
Current Liabilities Q3 2025 · Dec 31, 2024 $9.79M
Total Liabilities Q3 2025 · Sep 30, 2025 $27.06M
Total Liabilities Q3 2025 · Dec 31, 2024 $13.05M
Current Assets Q3 2025 · Sep 30, 2025 $917K
Current Assets Q3 2025 · Dec 31, 2024 $2.45M
Total Assets Q3 2025 · Sep 30, 2025 $18.21M
Total Assets Q3 2025 · Dec 31, 2024 $20.29M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.12
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.41
Eps Diluted Q3 2025 · Sep 30, 2024 $0.06
Eps Diluted Q3 2025 · Sep 30, 2024 $0.03
Eps Basic Q3 2025 · Sep 30, 2025 −$0.12
Eps Basic Q3 2025 · Sep 30, 2025 −$1.41
Eps Basic Q3 2025 · Sep 30, 2024 $0.37
Eps Basic Q3 2025 · Sep 30, 2024 $0.23
Sga Expense Q3 2025 · Sep 30, 2025 $261K
Sga Expense Q3 2025 · Sep 30, 2025 $755K
Sga Expense Q3 2025 · Sep 30, 2024 $132K
Sga Expense Q3 2025 · Sep 30, 2024 $424K
Rd Expense Q3 2025 · Sep 30, 2025 $52K
Rd Expense Q3 2025 · Sep 30, 2025 $230K
Rd Expense Q3 2025 · Sep 30, 2024 $82K
Rd Expense Q3 2025 · Sep 30, 2024 $386K
Net Income Q3 2025 · Sep 30, 2025 −$1.47M
Net Income Q3 2025 · Sep 30, 2025 −$17.08M
Net Income Q3 2025 · Sep 30, 2024 $4.25M
Net Income restated Q3 2025 · Sep 30, 2024 $2.4M
Operating Income Q3 2025 · Sep 30, 2025 −$948K
Operating Income Q3 2025 · Sep 30, 2025 −$3.11M
Operating Income Q3 2025 · Sep 30, 2024 −$1.13M
Operating Income Q3 2025 · Sep 30, 2024 −$2.52M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $1K
Cost Of Revenue Q3 2025 · Sep 30, 2025 $2K
Revenue Q3 2025 · Sep 30, 2025 $18K
Revenue Q3 2025 · Sep 30, 2025 $25K